The Essential Relationship Between Surgeon and Pathologist
It is rare that a surgical patient ever meets his or her pathologist. Although interacting with one’s surgeon is commonplace, a patients does not often get to know the medical specialists who work behind the scenes to deliver care. In this episode of The Recovery Room, host Dr. Rick Greene speaks with two experts about the surgeon-pathologist relationship, each from the respective fields of surgery and pathology: Carolyn Compton, MD, an academic pathologist at Arizona State University, and Terry Sarantou, MD, FACS, a surgical oncologist at the Levine Cancer Institute.
March 16, 2015
Mammography Screening—Benefits and Controversies
To sort out the competing narratives around mammographic screening, episode 24 of The Recovery Room Show features two leading experts in the field. Host Dr. Rick Greene interviews Cary Kaufman, MD, FACS, and Carl D’Orsi, MD, about their approach to breast screening.
August 13, 2014
Smoking Cessation and the Surgical Patient
What are the operative risks for surgical patients who smoke cigarettes? Is quitting cold turkey the best option? Should patients be tested for nicotine prior to having an operation? In this episode of The Recovery Room, host Dr. Rick Greene speaks with two experts, Eric Skipper, MD, FACS, and Michael Rosen, MD, FACS, about their experiences in working with surgical patients who smoke.
February 26, 2014
ACS NSQIP® Surgical Risk Calculator
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) Surgical Risk Calculator is a tool that provides a better understanding of a particular patient’s risks before heading into the operating room. In this episode of The Recovery Room, host Dr. Rick Greene speaks with two surgeons who developed this tool: Clifford Y. Ko, MD, FACS, and Karl Bilimoria, MD, FACS. Drs. Ko and Bilimoria share their thoughts on the usefulness of risk calculator and how it can best serve both the patient and the surgeon.
October 31, 2013
Managing Breast Cancer in the Era of Genetic Testing
In this episode of The Recovery Room
, host Dr. Rick Greene explores questions of mastectomy vs. lumpectomy, informed consent, and other issues related to breast cancer and genetic testing with his panel of experts consisting of David R. Byrd, MD, Rebecca Nagy, MS, CGC, and Lance Stell, PhD. The episode explores the surgical, ethical, and counseling aspects of genetic testing in breast cancer treatment.
October 1, 2013
Sun Exposure and Skin Cancer
With the height of summer now here, having the knowledge of how to protect your skin from the sun is particularly important. Today, the labels on sunscreen products use terms like “broad spectrum” and boast increasingly higher SPF numbers, making the choice of the right products a challenge. Is there a difference between sunblock and sunscreen? What do the SPF numbers mean? Are tanning beds safer than direct exposure to the sun? In this episode, host Dr. Rick Greene speaks with two experts, Briana Heniford, MD, and Jeffrey Gershenwald, MD, FACS, about issues related to sun protection and skin cancer.
August 16, 2013
Integrative Medicine as a Whole Patient Approach
What is integrative medicine? And how mainstream is it? This “whole person” approach to medicine is gaining importance, particularly in the area of oncology care. Integrative medicine is part of overall medical practices that are used to treat patients, and extends into treatment during survivorship. Integrative medicine seeks to treat the whole patient, not just the disease. In this episode, we speak with Barrie Cassileth, PhD, a nationally recognized leader in the field, about the practice and perception of integrative medicine.
July 24, 2013
Electronic Health Records, Medical Liability
Medicine is no stranger to the technological cutting edge. In many respects, it’s been a great innovator and adopter of new technologies. But when it comes to record keeping, the medical industry is still in the dark ages. While other industries have long gone digital, the bulk of record keeping in U.S. hospitals is still being done on paper. Harvard researcher Ashish Jha has published a troubling progress report about electronic health record adoption rates. On today’s show, we talk with Dr. Jha about what’s taking medicine so long to go digital – and what the delay means for patient safety. And later in the show, Jha’s colleague at the Harvard School of Public Health, Michelle Mello, puts a dollar figure on a politically divisive area of medicine: medical liability and defensive medicine spending.
September 30, 2010
A Watershed Moment for Health Care Accountability
If you’ve ever tried to find consumer ratings for a surgeon the way you might compare plumbers or car mechanics, you know that the information is almost impossible to find. How many patients survive surgery? How many went home with complications? Performance data for surgeons or surgical groups—or hospitals, for that matter—when it exists at all—hasn’t been available to the public. That’s starting to change. On today’s show, we talk with Dr. Dave Shahian from the Society of Thoracic Surgeons. The society of heart and lung specialists recently released performance data for the first time in what some are calling a “watershed moment” for health-care accountability. The resulting ratings of surgical groups are currently available in the most recent issue of Consumer Reports and on the magazine’s website. Later in the show, we’ll speak with John Santa. He’s the director of Consumer Reports Health Ratings Center.
September 25, 2010
The Law, the Lord & the Lab - The Legal, Ethical & Scientific Debate About Stem Cell Research
Ever since the embryonic stem cell was first isolated a dozen years ago, stem cell research has been at the mercy of shifting political tides, public debate, and legal challenges. The current court battle has put millions of dollars of grant money for stem cell research at risk. On today’s show, we unravel the current legal and ethical debate with the help of bioethicist Laurie Zoloth, and later in the show we’ll talk with Dr. Tim Kamp, a prominent stem cell researcher about when the promise of stem cell research will start becoming a reality.
September 17, 2010